December 4, 2015in Blogs, Canada, IP Intensive, Patents, Pharmaceutical Drugs, Uncategorized, US0by Editor1252 What Should Be Included in a Canadian Orphan Drug Regulatory Framework As the new Liberal government turns its mind to the application of substantive policies, it will have to decide what to do with the Canadian orphan drug regulatory framework (ODRF)…
